Antisense-mediated Inhibition of Aminopeptidase N (CD13) Markedly Decreases Growth Rates of Hematopoietic Tumour Cells
Overview
General Medicine
Authors
Affiliations
Shimizu T, Tanaka S, Kitagawa Y, Sakaguchi Y, Kamiya M, Takayanagi S Front Surg. 2024; 11:1298709.
PMID: 38516394 PMC: 10954885. DOI: 10.3389/fsurg.2024.1298709.
RamachandraRao S, Matthias M, Kokoy-Mondragon C, Mondrogon C, Aghania E, Park C PLoS Negl Trop Dis. 2015; 9(3):e0003640.
PMID: 25793258 PMC: 4368819. DOI: 10.1371/journal.pntd.0003640.
The moonlighting enzyme CD13: old and new functions to target.
Mina-Osorio P Trends Mol Med. 2008; 14(8):361-71.
PMID: 18603472 PMC: 7106361. DOI: 10.1016/j.molmed.2008.06.003.
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M, Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S BMC Cancer. 2007; 7:140.
PMID: 17655775 PMC: 2000898. DOI: 10.1186/1471-2407-7-140.
Bauvois B, Dauzonne D Med Res Rev. 2005; 26(1):88-130.
PMID: 16216010 PMC: 7168514. DOI: 10.1002/med.20044.